BCAL Diagnostics Limited · ASX:BDX
Jayne Shaw bought 67,685 BCAL Diagnostics Limited shares (Appendix 3Y, ASX)
Traded Nov 17, 2026 · Filed Nov 18, 2026
On Nov 17, 2026, Jayne Shaw (Director) bought 67,685 BCAL Diagnostics Limited shares at AUD 0.06 for AUD 4,036. Filed Nov 18, 2026 (Appendix 3Y, ASX).
- Bought
- 67,685 shares
- Price
- AUD 0.06
- Value
- AUD 4,036
- Role
- Director
The filing in full
Appendix 3Y
*Rule 3.19A.2*
Change of Director’s Interest Notice
*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*
Introduced 30/9/2001.
| Name of entity | BCAL DIAGNOSTICS LIMITED |
|---|---|
| ABN | 51 142 051 223 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
| Name of Director | Jayne Shaw |
|---|---|
| Date of last notice | 11 November 2026 |
Part 1 - Change of director’s relevant interests in securities
*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
| Direct or indirect interest | Direct & Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Entities controlled by the Director |
| Date of change | 17 November 2026 |
| No. of securities held prior to change | Nabelle Pty Ltd 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,394,796 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027. |
| Class | Ordinary shares |
| Number acquired | 67,685 |
---
| Number disposed | Nil |
|---|---|
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | $4,036 |
| No. of securities held after change | Nabelle Pty Ltd 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,462,481 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027. |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | On Market Purchase |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract N/A
Detail of contractN/ANature of interestName of registered holder (if issued securities)Date of changeNo. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedInterest acquiredInterest disposedValue/Consideration Note: If consideration is non-cash, provide details and an estimated valuationInterest after changePart 3 – +Closed periodWere the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?NoIf so, was prior written clearance provided to allow the trade to proceed during this period?N/AIf prior written clearance was provided, on what date was this provided?N/A
- See chapter 19 for defined terms.
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Ordinary shares | Buy | 67,685 | AUD 0.06 |
Source
Download PDF · View original at ASX